Unknown

Dataset Information

0

Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression.


ABSTRACT: The signaling mechanisms between prostate cancer cells and infiltrating immune cells may illuminate novel therapeutic approaches. Here, utilizing a prostate adenocarcinoma model driven by loss of Pten and Smad4, we identify polymorphonuclear myeloid-derived suppressor cells (MDSC) as the major infiltrating immune cell type, and depletion of MDSCs blocks progression. Employing a novel dual reporter prostate cancer model, epithelial and stromal transcriptomic profiling identified CXCL5 as a cancer-secreted chemokine to attract CXCR2-expressing MDSCs, and, correspondingly, pharmacologic inhibition of CXCR2 impeded tumor progression. Integrated analyses identified hyperactivated Hippo-YAP signaling in driving CXCL5 upregulation in cancer cells through the YAP-TEAD complex and promoting MDSC recruitment. Clinicopathologic studies reveal upregulation and activation of YAP1 in a subset of human prostate tumors, and the YAP1 signature is enriched in primary prostate tumor samples with stronger expression of MDSC-relevant genes. Together, YAP-driven MDSC recruitment via heterotypic CXCL5-CXCR2 signaling reveals an effective therapeutic strategy for advanced prostate cancer.We demonstrate a critical role of MDSCs in prostate tumor progression and discover a cancer cell nonautonomous function of the Hippo-YAP pathway in regulation of CXCL5, a ligand for CXCR2-expressing MDSCs. Pharmacologic elimination of MDSCs or blocking the heterotypic CXCL5-CXCR2 signaling circuit elicits robust antitumor responses and prolongs survival.

SUBMITTER: Wang G 

PROVIDER: S-EPMC4707102 | biostudies-literature | 2016 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Unlabelled</h4>The signaling mechanisms between prostate cancer cells and infiltrating immune cells may illuminate novel therapeutic approaches. Here, utilizing a prostate adenocarcinoma model driven by loss of Pten and Smad4, we identify polymorphonuclear myeloid-derived suppressor cells (MDSC) as the major infiltrating immune cell type, and depletion of MDSCs blocks progression. Employing a novel dual reporter prostate cancer model, epithelial and stromal transcriptomic profiling identifie  ...[more]

Similar Datasets

| S-EPMC5114612 | biostudies-literature
| S-EPMC7051186 | biostudies-literature
| S-EPMC9254473 | biostudies-literature
| S-EPMC6980695 | biostudies-literature
| S-EPMC4905460 | biostudies-literature
| S-EPMC5928767 | biostudies-literature
2020-04-30 | GSE147044 | GEO
| S-EPMC5827952 | biostudies-literature
| S-EPMC3989628 | biostudies-literature
| S-EPMC4654365 | biostudies-other